COVID Resources - POCTRN
COVID-19 Resources
A curated list of the latest COVID-19 information such as federal agency guidance, funding opportunities, and resources for researchers.
Funding Opportunities
NIH
- Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
- Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
- Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
- Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)
- Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)
- NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)
- NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional)
- Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
- Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network
- Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials
- Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
- Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations
- Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21, Clinical Trial Not Allowed)
- Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01, Clinical Trial Not Allowed)
- Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional)
- Administrative Supplement
- Notice of Special Interest regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
- Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
- Notice of Special Interest regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
- Notice of Special Interest: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
- Notice of Special Interest: National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
- Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
- Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA
- Notice of Special Interest regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
- Notice of Special Interest regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
- Notice of Special Interest: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
- Notice of Special Interest: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
- Notice of Special Interest: Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
- NCATS Opportunities
DOD
Department of Energy
NSF
- NSF Rapid Research on Coronavirus (COVID-19) for U.S. institutions
- Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
BARDA
- 2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
PCORI
- PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects
- PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards
Mozilla
US International Development Finance Corporation (DFC)
Wellcome Trust, the Bill and Melinda Gates Foundation and Mastercard
Federal Ministry of Education and Research, Germany
Instituto de Salud
FDA Emergency Guidance
- FDA Guidance on Emergency Authorization
- FDA COVID-19 Emergency Use Authorizations for In Vitro Diagnostics
- FDA COVID-19 Emergency Use Authorizations for High Complexity Molecular-Based Laboratory Developed Tests
- FDA COVID-19 Emergency Use Authorizations for Personal Protective Equipment
- FDA COVID-19 Emergency Use Authorizations for Ventilators and other Medical Devices
- FDA COVID-19 Emergency Use Authorizations for Therapeutics
NIH Guidance, Resources, Training, and Updates
- LitCovid
- NIBIB Response to COVID-19
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
- Roundup of New COVID-19 Resources for NIH Applicants and Recipients: Part 2
- NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool
- NIH COVID-19 Resources and News Releases
- Open-Access Data and Computational Resources to Address COVID-19
- NCBI Virus’ COVID-19 data hub
- GenBank COVID-19 Sequences
- COVID-19 Clinical Trials
- Coronaviruses
- Coronavirus Resources
- Coronavirus news and resources for global health researchers
- NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options
- Training resources for coronavirus workers dealing with the spread of COVID-19
CDC Guidance and Resources
- Guidance for Healthcare Professionals
- COVID-19 (2019 Novel Coronavirus) Research Guide
- Research Articles Downloadable Database
- Secondary data and statistics sources to help researchers find data on COVID-19
- Centers for Disease Control and Prevention’s Situation Summary
- Public Health Genomics and Precision Health Knowledge Base (v6.2.2)